Which dry‑cough medications are safe for an adult with myasthenia gravis?

Safe Cough Medications for Myasthenia Gravis

Dextromethorphan and menthol are the safest first-line options for dry cough in adults with myasthenia gravis, as they lack the neuromuscular junction effects and significant adverse profiles of other antitussives.

Recommended Agents

Dextromethorphan (Preferred)

• Dextromethorphan is a non-sedating central cough suppressant that has demonstrated efficacy in suppressing acute cough and is safe in myasthenia gravis 1.
• The standard over-the-counter dosage is often subtherapeutic; maximum cough reflex suppression occurs at 60 mg with prolonged effect 1.
• When selecting dextromethorphan preparations, verify that combination products do not contain other ingredients like paracetamol at doses that would be excessive when taking higher dextromethorphan doses 1.
• This agent works through central modulation of the cough reflex without affecting neuromuscular transmission 1.

Menthol (Alternative or Adjunct)

• Menthol by inhalation provides acute, short-lived cough reflex suppression 1.
• Can be prescribed as menthol crystals BPC or proprietary capsules 1.
• The rapid onset but brief duration makes it suitable for acute symptom relief 1.

Agents to Use With Caution

First-Generation Antihistamines

• Sedating antihistamines (e.g., diphenhydramine) suppress cough but cause drowsiness 1.
• May be appropriate specifically for nocturnal cough when sedation is acceptable 1.
• The sedative properties, not anticholinergic effects, provide the antitussive benefit 1.

Agents to Avoid

Codeine and Other Opiates

• Codeine and pholcodine have no greater efficacy than dextromethorphan but carry a significantly greater adverse side effect profile and are not recommended 1.
• Opiate antitussives have substantial adverse effects that outweigh benefits in most cough scenarios 1.
• The ACCP guidelines support codeine only for chronic bronchitis, not for general cough suppression 2.

Ipratropium Bromide

• While ipratropium is recommended for cough due to upper respiratory infection or bronchitis, it is an inhaled anticholinergic agent 2.
• In myasthenia gravis, anticholinergic medications can theoretically interfere with acetylcholine at the neuromuscular junction, though ipratropium's inhaled route limits systemic effects.

Critical Considerations for Myasthenia Gravis

• Many medications are classically contraindicated in myasthenia gravis due to risk of exacerbating muscle weakness 3.
• A recent large French database study found that 89.6% of MG patients received some contraindicated treatment during follow-up, highlighting the complexity of medication management in this population 3.
• The key principle is avoiding medications that directly impair neuromuscular transmission or have significant systemic anticholinergic effects.
• Dextromethorphan's mechanism of central cough suppression without peripheral neuromuscular effects makes it the optimal choice 1.

Non-Pharmacologic Approach

• Simple home remedies such as honey and lemon may provide symptomatic relief through central modulation of the cough reflex 1.
• Voluntary cough suppression techniques can reduce cough frequency without medication 1.

Important Caveat

If the patient with myasthenia gravis develops cough-variant asthma (which can occur even in immunosuppressed MG patients), inhaled corticosteroids and long-acting beta-agonists are appropriate and effective treatments 4. This diagnosis should be considered if simple antitussives fail, particularly in patients with allergic diathesis 4.